CD4 T cell-released exosomes inhibit CD8 cytotoxic T-lymphocyte responses and antitumor immunity

Cellular and Molecular Immunology

Volumn 8, Issue 1, 2011, Pages 23-30

  Zhang, Haifeng ^a   Xie, Yufeng ^a   Li, Wei ^a   Chibbar, Rajni ^a   Xiong, Sidong ^b   Xiang, Jim ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

antitumor immunity; CTL; T cell exosome

Indexed keywords

CD4 ANTIGEN; FAS LIGAND; INTERLEUKIN 2 RECEPTOR ALPHA; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OVALBUMIN; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COCULTURE; CONTROLLED STUDY; DENDRITIC CELL; ELECTRON MICROSCOPY; EXOSOME; FEMALE; FLOW CYTOMETRY; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PARTICLE SIZE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SOLID TUMOR; SUPERNATANT; TRANSGENIC MOUSE; TUMOR IMMUNITY; ULTRACENTRIFUGATION; WESTERN BLOTTING; WILD TYPE;

ANIMALS; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; EXOSOMES; FEMALE; GRAFT REJECTION; IMMUNITY; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASM TRANSPLANTATION; OVALBUMIN; T-LYMPHOCYTES, CYTOTOXIC;

MUS;

EID: 79952459878     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2010.59     Document Type: Article

References (38)

1. Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002; 2: 569-579.
2. Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009; 9: 581-593.
3. Zitvogel L, Regnault A, Lozier A, Wolfers J, Flament C, Tenza D et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med 1998; 4: 594-600. (Pubitemid 28237359)
4. Hwang I, Shen X, Sprent J. Direct stimulation of naive T cells by membrane vesicles from antigen-presenting cells: distinct roles for CD54 and B7 molecules. Proc Natl Acad Sci USA 2003; 100: 6670-6675. (Pubitemid 36666639)
5. Andre F, Chaput N, Schartz NE, Flament C, Aubert N, Bernard J et al. Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells. J Immunol 2004; 172: 2126-2136. (Pubitemid 38182358)
6. Hao S, Moyana T, Xiang J. Review: cancer immunotherapy by exosome-based vaccines. Cancer Biother Radiopharm 2007; 22: 692-703. (Pubitemid 350059006)
7. Chen W, Wang J, Shao C, Liu S, Yu Y, Wang Q et al. Efficient induction of antitumorT cell immunitybyexosomesderivedfrom heat-shocked lymphomacells. Eur J Immunol 2006;36:1598-1607. (Pubitemid 43942147)
8. Blanchard N, Lankar D, Faure F, Regnault A, Dumont C, Raposo Get al. TCRactivation of human T cells induces the production of exosomes bearing the TCR/CD3/zeta complex. J Immunol 2002; 168: 3235-3241. (Pubitemid 34250383)
9. Martinez-Lorenzo MJ, Anel A, Gamen S, Monlen I, Lasierra P, Larrad Let al. Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles. J Immunol1999; 163: 1274-1281. (Pubitemid 29352744)
10. Monleon I, Martinez-Lorenzo MJ, Monteagudo L, Lasierra P, Taules M, Iturralde M et al. Differential secretion of Fas ligand-or APO2 ligand/TNF-related apoptosis-inducing ligand-carrying microvesicles during activation-induced death of human T cells. J Immunol 2001; 167: 6736-6744. (Pubitemid 33144163)
11. Nolte't Hoen EN, Wagenaar-Hilbers JP, Peters PJ, Gadella BM, van Eden W, Wauben MH. Uptake of membrane molecules from T cells endows antigen-presenting cells with novel functional properties. Eur J Immunol 2004; 34: 3115-3125. (Pubitemid 39549390)
12. + Tcell responses. J Immunol 2009; 182: 193-206.
13. + Tr1 cell responses. Cancer Res 2009;69: 7756-7766.
14. + CTL responses and antitumor immunity than tumor cell-derived exosomes. Cell Mol Immunol 2006; 3: 205-211.
15. Thery C, Boussac M, Veron P, Ricciardi-Castagnoli P, Raposo G, Garin J et al. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol 2001; 166: 7309-7318. (Pubitemid 32525606)
16. + T cell help. J Exp Med 1997; 186: 65-70. (Pubitemid 27304848)
17. + T-helper and a T-killer cell. Nature 1998; 393: 474-478.
18. Davis DM. Intercellular transfer of cell-surface proteins is common and can affect many stages of an immune response. Nat Rev Immunol 2007; 7: 238-243.
19. Williams ME, Densmore JJ, Pawluczkowycz AW, Beum PV, Kennedy AD, Lindorfer MA et al. Thrice-weeklylow-doserituximabdecreasesCD20 loss viashavingandpromotes enhanced targeting in chronic lymphocytic leukemia. J Immunol 2006; 177: 7435-7443. (Pubitemid 44715114)
20. Huang JF, Yang Y, Sepulveda H, Shi W, Hwang I, Peterson PA et al. TCR-Mediated internalization of peptide-MHC complexes acquired by T cells. Science 1999; 286: 952-954.
21. + Tcell acquisition of the bystander pMHC I colocalizing in the same immunological synapse comprising pMHC II and costimulatory CD40, CD54, CD80, OX40L, and 41BBL. Biochem Biophys Res Commun 2007; 362: 822-828. (Pubitemid 47390647)
22. + CTL responses. J Immunol 2007; 179: 2731-2740.
23. + T cells directly from the immunological synapse upon cellular dissociation. J Immunol 2005; 174: 80-89. (Pubitemid 40007394)
24. Taams LS, van Eden W, Wauben MH. Antigen presentation by T cells versus professional antigen-presenting cells (APC): differential consequences for T cell activation and subsequent T cell-APC interactions. Eur J Immunol 1999; 29: 1543-1550. (Pubitemid 29224459)
25. + T cells involving acquired MHC class II:peptide complexes: another mechanism to limit clonal expansion? Blood 2003; 101: 2704-2710. (Pubitemid 36857633)
26. Helft J, Jacquet A, Joncker NT, Grandjean I, Dorothee G, Kissenpfennig A et al. Antigen-specific T-T interactions regulate CD4 T-cell expansion. Blood 2008; 112: 1249-1258.
27. + CTL responses and long-term T cell memory. J Leukoc Biol 2007; 82: 829-838. (Pubitemid 47511043)
28. He T, Tang C, Liu Y, Ye Z, Wu X, Wei Yet al. Bidirectional membranemolecule transfer between dendritic and T cells. Biochem Biophys Res Commun 2007; 359: 202-208. (Pubitemid 46880494)
29. + T cell priming involves two distinct mechanisms. J Immunol 2008; 181: 3965-3973.
30. Daubeuf S, Lindorfer MA, Taylor RP, Joly E, Hudrisier D. The direction of plasma membrane exchange between lymphocytes and accessory cells by trogocytosis is influenced by the nature of the accessorycell. J Immunol 2010; 184: 1897-1908.
31. Ahmed KA, Munegowda MA, Xie Y, Xiang J. Intercellular trogocytosis plays an important role in modulation of immune responses. Cell Mol Immunol 2008; 5: 261-269.
32. Undale AH, van den Elsen PJ, Celis E. Antigen-independentacquisition of MHCclass II molecules by human T lymphocytes. Int Immunol 2004; 16: 1523-1533. (Pubitemid 39341566)
33. Kedl RM, Schaefer BC, Kappler JW, Marrack P. T cellsdown-modulate peptide-MHC complexes on APCs in vivo. Nat Immunol 2002; 3: 27-32. (Pubitemid 34065614)
34. Andreola G, Rivoltini L, Castelli C, Huber V, Perego P, Deho P et al. Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J Exp Med 2002; 195: 1303-1316. (Pubitemid 34564332)
35. Taylor DD, Gercel-Taylor C, Lyons KS, Stanson J, Whiteside TL. T-cell apoptosis and suppression of T-cell receptor/CD3-zeta by Fas ligand-containing membranevesicles shed from ovarian tumors. Clin Cancer Res 2003; 9: 5113-5119. (Pubitemid 37413559)
36. + T-cell apoptosis. Blood Cells Mol Dis 2005; 35:169-173. (Pubitemid 41267045)
37. + Tcells. Nat Med 2010; 16: 713-717.
38. Russell JH, Ley TJ. Lymphocyte-mediatedcytotoxicity. Annu Rev Immunol 2002; 20: 323-370.